|Description||Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed.|
|B0084-072903||2.5 g||$198||In stock|
|B0084-072903||5 g||$348||In stock|
|Appearance||Pale Beige to Yellow Solid|
|Solubility||DMSO (Slightly), Methanol (Slightly)|
|Application||Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.|
|Quality Standard||CP standard|
|Quantity||Kilograms to Tons|
|Boiling Point||451.5±45.0 °C | Condition: Press: 760 Torr|
|Melting Point||295 °C (decomp)|
|Density||1.277±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
|Current Developer||Amrinone was developed by Sanofi and has been listed.|
Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic ag...
JNJ-10258859 is a novel, potent, and selective phosphodiesterase type 5 inhibitor 5 with a K(i) of 0.23 nM and displayed excellent selectivity versus phosphodie...
Filaminast is a Type 4 cyclic nucleotide phosphodiesterase inhibitor. It is an analog of rolipram which served as a prototype molecule for several development e...
K134 is a selective phosphodiesterase 3 (PDE3) inhibitor, and has been shown to exhibit more potent anti-platelet activity than cilostazol. In vivo studies have...
L791943 is a highly potent and metabolically stable PDE4 inhibitor with good in vitro activity (IC50= 4.2 nM). L-791, 943 is potent in vitro and in vivo as demo...
Milrinone is a phosphodiesterase 3 (PDE3) inhibitor with vasodilator properties, used to increase the heart's contractility. It increases erythrocyte cAMP activ...
PDE-9 inhibitor is useful for neurodegenerative diseases.
EHNA hydrochloride is a selective inhibitor of cGMP-stimulated phosphodiesterase (PDE2) (IC50 = 0.8 - 4 μM) and also an inhibitor of adenosine deaminase. EHNA i...